Indiva Engages Independent Trading Group as Market-Maker and Investor Relations and Marketing Firm

LONDON, Ontario, March 05, 2021 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, today announced that it has engaged the services of Independent Trading Group Inc. (“ITG“) as market-maker for its common shares on the TSX Venture Exchange and Stonegate Capital Partner (“Stonegate“), to lead a new investor communications and outreach program.
Market MakerUnder the terms of the agreement, the Company has engaged ITG for a period of three (3) months and the agreement will renew for subsequent one (1) month periods, until either party has terminated the agreement with thirty (30) days’ notice. The Company will pay ITG a monthly fee of $5,000 for market making services. At the time of this agreement, neither ITG nor its principals have any direct or indirect interest in Company securities. The engagement of ITG remains subject to the approval of the TSX Venture Exchange.ITG is Canada’s only brokerage firm dedicated specifically to professional trading. As Canada’s foremost Market Making Firm, ITG provides Market Making and Liquidity Provider services that are objective and focused. ITG employs real traders and provides real liquidity, with an underlying emphasis on integrity and success. ITG was established by a group of Toronto Floor Traders in 1992 with the intent of developing a business where Market Makers could conduct business in a professional manner without conflict or compromise.Investor Relations and Marketing ContractThe Company has engaged Stonegate, a Dallas-based firm, to lead a new investor communications and outreach program. Under the terms of the agreement, the Company has engaged Stonegate for one (1) month and the agreement will renew for subsequent one (1) month periods, until either party has terminated the agreement with ten (10) days’ notice. The Company has agreed to pay Stonegate US$3,000 per month for an initial term and any renewal term. Stonegate will work closely with the Company’s management to refine and deliver the company’s message and assist with outreach to investors. Stonegate is a privately held firm that aims to help companies like Indiva enhance its shareholder value by delivering the right message to the right audience, and building high quality, long-term relationships in the investment community. Stonegate will also publish a research report on the Company. Stonegate is a leading advisory firm founded in 1972. The Company specializes in capital markets advisory with a focus on institutional investor outreach for publicly traded companies. Additional information can be found at www.stonegateinc.com. To the Company’s knowledge, Stonegate does not have any direct interest in the Company or its securities. The engagement of ITG remains subject to the approval of the TSX Venture Exchange.ABOUT INDIVAIndiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, and edible products and provides production and manufacturing services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Wana™ Sour Gummies, Ruby® Jewels Chewable Tablets, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Artisan Batch, and other Powered by INDIVA™ products through license agreements and partnerships. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.CONTACTS
INVESTOR CONTACT
Anthony Simone
Phone: 416-881-5154
Email: ir@indiva.comDISCLAIMER AND READER ADVISORYNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company’s future operations, future results, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry, future sales, the demand for the Company’s products and cannabis products generally and the continued operations of the Company in the ordinary course. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.